40th Annual J.P. Morgan Healthcare Conference Presentation

How is Repligen Winning in the Bioprocessing Market? R REPLIGEN Strategic M&A ● ● Strict M&A criteria Rapid growth of acquired companies R&D Innovation and Partnerships First-to-market product introductions Market-leading technologies. Collaborations with industry leaders in key growth areas ● ● Operational Excellence Capacity expansion, multi-site manufacturing Global commercial footprint 6

View entire presentation